{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:29:23Z","timestamp":1788449363286,"version":"build-2803163510"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>Mild inflammatory diabetic neuropathies (IDNs) overlap with diabetic sensorimotor neuropathy (DPN) in clinical presentation and electrophysiological and laboratory tests. This study is to determine whether IDN can be differentiated from DPN by clinical features, electrophysiological, pathological, or laboratory tests.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Suspected IDN cases were identified by a subacute onset and progressive sensory or motor neuropathy in patients with diabetes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>IDN occurred earlier in the course of diabetes mellitus and had higher prevalence of limb weakness, walking difficulty, and more severe electrophysiological abnormalities suggesting both demyelination and axonal loss. Sensory nerve biopsies in IDN showed perivascular inflammatory infiltrates, decreased fiber density, increased demyelination, and axonal degeneration. Most patients with IDN improved with immunotherapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Features that favor IDN over DPN are limb weakness, more severe nerve conduction abnormalities, inflammatory infiltrates on nerve biopsy, and a favorable response to immunotherapy. A nerve biopsy can help establish an inflammatory cause.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cnd.0000000000000207","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T01:37:18Z","timestamp":1534729038000},"page":"7-13","source":"Crossref","is-referenced-by-count":3,"title":["Inflammatory Diabetic Neuropathy: Helpful Diagnostic Parameters"],"prefix":"10.1097","volume":"20","author":[{"given":"Pariwat","family":"Thaisetthawatkul","sequence":"first","affiliation":[{"name":"Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Americo","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE;"},{"name":"Neurology Section, VA Nebraska Western Iowa Health Care System, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezequiel","family":"Piccione","sequence":"additional","affiliation":[{"name":"Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Truong","sequence":"additional","affiliation":[{"name":"Creighton University, Omaha, NE; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. James B.","family":"Dyck","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pmr.2007.10.010","article-title":"The spectrum of diabetic neuropathies","volume":"19","author":"Tracy","year":"2008","journal-title":"Phys Med Rehabil Clin N Am."},{"key":"R2-20230905","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1212\/WNL.43.4.817","article-title":"The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study","volume":"43","author":"Dyck","year":"1993","journal-title":"Neurology"},{"key":"R3-20230905","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/jnnp.2005.075119","article-title":"Additional causes for distal sensory polyneuropathy in diabetic patients","volume":"77","author":"Gorson","year":"2006","journal-title":"J Neurol Neurosurg Psychiatr."},{"key":"R4-20230905","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s004150200066","article-title":"Symptomatic diabetic and non-diabetic neuropathies in a series of 100 diabetic patients","volume":"249","author":"Lozeron","year":"2002","journal-title":"J Neurol."},{"key":"R5-20230905","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1212\/WNL.53.9.2113","article-title":"Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy","volume":"53","author":"Dyck","year":"1999","journal-title":"Neurology"},{"key":"R6-20230905","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/mus.10204","article-title":"Conduction slowing in diabetic distal polyneuropathy","volume":"26","author":"Herrmann","year":"2002","journal-title":"Muscle Nerve"},{"key":"R7-20230905","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410190503","article-title":"Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy","volume":"19","author":"Dyck","year":"1986","journal-title":"Ann Neurol."},{"key":"R8-20230905","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/ana.410130512","article-title":"Segmental demyelination and remyelination in lumbar spinal roots of patients dying with diabetes mellitus","volume":"13","author":"Ohnishi","year":"1983","journal-title":"Ann Neurol."},{"key":"R9-20230905","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/ana.22334","article-title":"Painless diabetic motor neuropathy: a variant of DLRPN","volume":"69","author":"Garces-Sanchez","year":"2011","journal-title":"Ann Neurol."},{"key":"R10-20230905","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/archneur.1961.00450070033004","article-title":"Cerebrospinal fluid protein in diabetes mellitus","volume":"4","author":"Kutt","year":"1961","journal-title":"Arch Neurol."},{"key":"R11-20230905","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.41.5.617","article-title":"Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force","volume":"41","year":"1991","journal-title":"Neurology"},{"key":"R13-20230905","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/brb3.177","article-title":"Comparison of diabetes patients with \u201cdemyelinating\u201d diabetic sensorimotor polyneuropathy to those diagnosed with CIDP","volume":"3","author":"Dunnigan","year":"2013","journal-title":"Brain Behav."}],"container-title":["Journal of Clinical Neuromuscular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00131402-201809000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T23:23:10Z","timestamp":1693956190000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00131402-201809000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/cnd.0000000000000207","relation":{},"ISSN":["1522-0443"],"issn-type":[{"value":"1522-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}